Quiet Contrarian. Ep52: Trades for January 2024
Buys Clinuvel Pharmaceuticals Ltd – CUV.ASX – They have a drug to treat severe phototoxicity (Scenesse), to my understanding they basically have a monopoly position in the market; and they are looking for new opportunities to increase sales by applying the drug to the treatment of other conditions (e.g. vitiligo). I bought on recent price weakness, which I think will be...